The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer - United Kingdom

doi 10.1186/s40425-015-0059-z